Cargando…

Stroke prevention in patients with atrial fibrillation and comorbidities: evidence and common sense

Detalles Bibliográficos
Autor principal:	de Groot, J. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2020
Materias:	Editor’s Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494716/ https://www.ncbi.nlm.nih.gov/pubmed/32897488 http://dx.doi.org/10.1007/s12471-020-01491-1

Ejemplares similares

New insights in prevention, diagnosis and treatment of stroke: its relation with atrial fibrillation
por: van der Wall, E. E.
Publicado: (2012)

Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?
por: de Groot, J. R., et al.
Publicado: (2022)

New evidence for the role of gut microbiota on atrial fibrillation development
por: Papandreou, Christopher
Publicado: (2023)

Polygenic risk scores for prediction of atrial fibrillation
por: Kavousi, Maryam, et al.
Publicado: (2022)

Stroke Prevention in Patients with Atrial Fibrillation
por: Kowey, Peter R.
Publicado: (2018)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Myocardial infarction, atrial fibrillation and mortality: timing is everything
por: van den Berg, N.W.E., et al.
Publicado: (2015)

Increasing sensitivity—a common-sense approach?
por: Michels, M., et al.
Publicado: (2019)

Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze
por: Berger, W. R., et al.
Publicado: (2013)

Left Atrial Ablation of Atrial Fibrillation: Is the Fly in the Ointment a Silent Stroke?
por: Nademanee, Koonlawee, et al.
Publicado: (2012)

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018)

Measurement of blood pressure in people with atrial fibrillation
por: Clark, Christopher E., et al.
Publicado: (2019)

The link between diabetes and atrial fibrillation: cause or correlation?
por: Sun, Yihong, et al.
Publicado: (2010)

Atrial fibrillation: A kiss of death?
por: de Boer, M. J.
Publicado: (2013)

Pulmonary vein remodeling in hypertension: Mechanistic insight into primary prevention of atrial fibrillation
por: Iwasaki, Yu-ki
Publicado: (2018)

Statins in paroxysmal atrial fibrillation: Beneficial to prevent recurrence but insufficient to stop progression
por: Polovina, Marija M.
Publicado: (2017)

Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity
por: Sagris, Dimitrios, et al.
Publicado: (2022)

Improving stroke prevention in patients with atrial fibrillation
por: Arts, Derk L, et al.
Publicado: (2013)

Left atrial appendage occluder implantation for stroke prevention in elderly patients with atrial fibrillation: acute and long-term results
por: Davtyan, Karapet V, et al.
Publicado: (2017)

Acute atrial wall stretch and the efficacy of flecainide-induced conversion of atrial fibrillation
por: van Hemel, N.M., et al.
Publicado: (2015)

Atrial Fibrillation:: A Common Cause of Stroke
por: Tai, Waimei
Publicado: (2023)

Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation
por: De Potter, Tom, et al.
Publicado: (2020)

Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation
por: Seeger, Julia, et al.
Publicado: (2020)

Secondary Prevention of Atrial Fibrillation: Is It Worth Doing?
por: De Vecchis, Renato
Publicado: (2019)

Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
por: Polovina, Marija, et al.
Publicado: (2017)

Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?
por: Baalman, S. W. E., et al.
Publicado: (2018)

Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes
por: Gokcal, Elif, et al.
Publicado: (2018)

Removing the Stress From Hypertension-Induced Atrial Fibrillation
por: Hennessey, Jessica A., et al.
Publicado: (2020)

Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
por: Lewicka, Ewa
Publicado: (2016)

An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation
por: Deedwania, Prakash, et al.
Publicado: (2012)

Ablation of idiopathic ventricular arrhythmias
por: de Groot, J. R.
Publicado: (2018)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

The wearable defibrillator: a most affordable vest
por: de Groot, J. R.
Publicado: (2017)

Clinical electrophysiology in the Netherlands: where do we stand?
por: de Groot, J. R.
Publicado: (2017)

What if there is no prospective, double blind, randomised trial?
por: de Groot, J. R.
Publicado: (2019)

Novel sites for pacemaker lead implantation and different routes for their extraction
por: de Groot, J. R.
Publicado: (2022)

Left Atrial Appendage Closure to Prevent Strokes and Ligation to Prevent Atrial Fibrillation
por: Ellis, Christopher R.
Publicado: (2017)

Would Left Atrial Strain Provide a Role as a New Prognostigator for Atrial Fibrillation?
por: Shin, Sung-Hee
Publicado: (2016)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
por: Li, Yan-Guang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5makt8vjnstc2nqslacgkmlkrk